IVF missed EPS expectations by 631.82%
May 15, 2025, 10:33 PM
0.00%
What does IVF do
INVO BioScience, based in Lakewood Ranch, Florida, specializes in assisted reproductive technology and offers the INVOcell device for in vivo fertilization, with three operational centers in North America. The company went public on November 11, 2008, and aims to make fertility care more accessible and affordable.
INVO Fertility (IVF) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, INVO Fertility's actual EPS was -$25.87, missing the estimate of -$3.54 per share, resulting in a -631.82% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.